Navigation Links
New Study Finds Use of Generic Prescription Drugs Saved Consumers and the U.S. Health Care System $1 Trillion over Past Decade
Date:8/2/2012

WASHINGTON, Aug. 2, 2012 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) today released an independently conducted analysis showing that the savings to consumers and the U.S. health care system from the use of generic prescription drugs has risen to a current rate of $1 billion every other day — totaling $193 billion in 2011 and more than $1 trillion over the last 10 years (2002-2011).

The Generic Drug Savings study was conducted for GPhA by the IMS Institute for Healthcare Informatics, the research division of IMS Health, a leading provider of information, services and technology for the health care industry around the world.

"The remarkable findings demonstrated in this report are a testament not only to the generic industry's tremendous accomplishments over the past decade, but to the even greater achievements that are still to come," said Ralph G. Neas, President and CEO of GPhA. "The Generic Drug Savings study shows conclusively that, as Congress and the White House gear up for the fiscal challenges facing them in the coming year, generic and biosimilar utilization are the best places to go for the 'offsets' that everyone will be desperately seeking. The sustainability of the health care system and the national economy depend in significant measure on the availability of affordable medicines."

Other findings of the Generic Drug Savings study show:

  • Savings from generics in 2011 increased 22 percent over the prior year, marking the largest year-over-year increase since 1998, and 10 percentage points higher than the 10-year average.
  • Savings from newer generic medicines — those that have entered the market since 2002 — continue to increase exponentially, totaling $481 billion over the past 10 years.
  • Generic versions of central nervous system drugs, such as antidepressants and anticonvulsants, and cardiovascular drugs account for 57 percent of the annual savings.
  • In 2011, nearly 80 percent of the 4 billion prescriptions written in the U.S. were dispensed using generic medicines, while accounting for only 27 percent of the total drug spending.

Even with these remarkable savings provided by generics, the innovation of new medicines has not slowed. Since the implementation of the Hatch-Waxman Act in 1984, there has been a multiple-fold increase in the innovation of new medicines, including the cholesterol drugs Lipitor® and Zocor®, the antidepressants Prozac® and Paxil®, and the blood thinner Plavix® to name a few. By creating a fair balance between innovation of new medicines and accessibility to lower-cost generic medicines, federal law has established a win-win for providers and American consumers.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 80 percent of the prescriptions dispensed in the U.S. but consume just 27 percent of the total drug spending. Additional information is available at gphaonline.org.

CONTACT: David Belian
202-249-7124

 


'/>"/>
SOURCE Generic Pharmaceutical Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2020)... ... March 30, 2020 , ... ... today announced it has launched a series of survey question packs that enable ... feedback to inform mission-critical decisions. As the current situation continues to evolve, The ...
(Date:3/30/2020)... ... March 30, 2020 , ... In order to provide ... appointments in addition to in-person visits. The San Diego-based leader in regenerative ... patients, health care professionals, and the community at large is the top priority. ...
(Date:3/27/2020)... ... March 27, 2020 , ... Nexus, a ... changing its name to Nexus Family Healing. For more than 45 years, Nexus ... families suffering from mental, emotional and behavioral issues. Moving forward, Nexus Family Healing ...
Breaking Medicine Technology:
(Date:4/1/2020)... ... April 01, 2020 , ... American hospital workers are in ... patients. , Staffers are in particular need of face shields, which protect them ... Wall Street Journal reported that New York City mayor Bill de Blasio's office ...
(Date:4/1/2020)... ... 2020 , ... “Medical information is considered to be among ... LLP attorney Eric A. Grover. “For that reason, healthcare providers are required ... disclosure of medical information can, under certain circumstances, give rise to claims by ...
(Date:3/28/2020)... (PRWEB) , ... March 27, 2020 , ... ... division of the Suntuity Group of companies, is mobilizing their drone equipment and ... coronavirus. , By leveraging their DJI Enterprise level Matrice and Agras drones, Suntuity ...
(Date:3/28/2020)... ... March 27, 2020 , ... To help prevent the spread ... as an alternative approach to seeing their patients. This approach will allow patients ... their own home or office using video conference and telecommunications technology, such as ...
(Date:3/28/2020)... ... 2020 , ... Confluent Health is proud to announce their ... since 1985 specializing in the treatment of orthopedic, sports, and work-related injuries with ... years ago, we have been committed to providing excellent quality of patient care ...
Breaking Medicine News(10 mins):